Repro-Med Systems, Inc. (NASDAQ:REPR) Director Joseph M. Jr. Manko bought 146,418 shares of the stock in a transaction dated Friday, September 15th. The shares were purchased at an average cost of $0.50 per share, for a total transaction of $73,209.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Repro-Med Systems, Inc. (NASDAQ:REPR) opened at 0.55 on Monday. The company’s 50 day moving average is $0.47 and its 200 day moving average is $0.43. The firm’s market cap is $20.80 million. Repro-Med Systems, Inc. has a 52-week low of $0.34 and a 52-week high of $0.59.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at

Repro-Med Systems Company Profile

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

Insider Buying and Selling by Quarter for Repro-Med Systems (NASDAQ:REPR)

Receive News & Stock Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related stocks with our FREE daily email newsletter.